Literature DB >> 23054355

Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization.

Petra Horka1, Karin Malickova, Radka Jarosova, Ivana Janatkova, Tomas Zima, Marta Kalousova.   

Abstract

PURPOSE: To assess levels of matrix metalloproteinases 2 and 9 (MMP-2 and MMP-9) in follicular fluids and sera of female patients undergoing in vitro fertilization (IVF) treatment, and discover the role of MMPs in IVF outcome prediction.
METHODS: Sera and follicular fluids were obtained from 58 female patients treated for infertility by IVF. Twenty-nine of them became pregnant after the embryo-transfer; another 29 were not successful in IVF and did not conceive. Forty female non-pregnant blood donors and 38 healthy pregnant patients in the first trimester after the physiological conception were examined as control groups. MMP-2 and MMP-9 were quantitively assessed using enzyme-linked immunosorbent assay.
RESULTS: IVF females successfully conceiving after the IVF have shown the highest MMP-9 concentrations in sera (833.5 {686.0;958.7} ng/mL) and follicular fluids (9.6 {6.0; 17.0} ng/mL) compared to all other examined cohorts. Different behavior of MMP-2 and MMP-9 during the artificial ovulation was confirmed, because only MMP-9 has shown a vast difference between serum and follicular concentrations.
CONCLUSIONS: MMP-9 could be a good predictor of the successful IVF outcome (pregnancy), which was proven for serum as well as follicular MMP-9 levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054355      PMCID: PMC3510381          DOI: 10.1007/s10815-012-9853-4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  25 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 2.  Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems.

Authors:  Tor Ny; Patrik Wahlberg; Ida J M Brändström
Journal:  Mol Cell Endocrinol       Date:  2002-02-22       Impact factor: 4.102

3.  Gelatinase B deficiency impairs reproduction.

Authors:  B Dubois; B Arnold; G Opdenakker
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries.

Authors:  S C Riley; A H Gibson; R Leask; D J Mauchline; H G Pedersen; E D Watson
Journal:  Reproduction       Date:  2001-04       Impact factor: 3.906

5.  Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat.

Authors:  T E Curry; L Song; S E Wheeler
Journal:  Biol Reprod       Date:  2001-09       Impact factor: 4.285

6.  Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.

Authors:  Valéria A Gomes; Carolina S Vieira; Anna L Jacob-Ferreira; Vanessa A Belo; Gustavo M Soares; Janaína B F Fernandes; Rui A Ferriani; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-03-25       Impact factor: 3.396

7.  Role of matrix metalloproteinase 2 in the ovulatory folliculo-luteal transition of ewes.

Authors:  M L Gottsch; E A Van Kirk; W J Murdoch
Journal:  Reproduction       Date:  2002-09       Impact factor: 3.906

8.  Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.

Authors:  Katsuhiko Naruse; Gendie E Lash; Barbara A Innes; Harry A Otun; Roger F Searle; Stephen C Robson; Judith N Bulmer
Journal:  Hum Reprod       Date:  2008-12-16       Impact factor: 6.918

9.  Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.

Authors:  Keiichi Isaka; Hirotaka Nishi; Hiromi Nakai; Toshihide Nakada; Yin Feng Li; Yoshiro Ebihara; Masaomi Takayama
Journal:  Cancer       Date:  2003-01-01       Impact factor: 6.860

Review 10.  Control of MMP-9 expression at the maternal-fetal interface.

Authors:  Paul Bischof; A Meisser; A Campana
Journal:  J Reprod Immunol       Date:  2002 May-Jun       Impact factor: 4.054

View more
  6 in total

Review 1.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

2.  Intrafollicular soluble RAGE benefits embryo development and predicts clinical pregnancy in infertile patients of advanced maternal age undergoing in vitro fertilization.

Authors:  Yu-Jie Li; Jian-Hui Chen; Peng Sun; Jing-Jie Li; Xiao-Yan Liang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-04-11

3.  Proteomic analysis of human follicular fluid from fertile women.

Authors:  Alberuni M Zamah; Maria E Hassis; Matthew E Albertolle; Katherine E Williams
Journal:  Clin Proteomics       Date:  2015-03-03       Impact factor: 3.988

4.  Matrix metalloproteinase 2 level in human follicular fluid is a reliable marker of human oocyte maturation in in vitro fertilization and intracytoplasmic sperm injection cycles.

Authors:  Wen-Jui Yang; Fon-Chang Liu; Jih-Sheng Hsieh; Ching-Hung Chen; Shun-Yu Hsiao; Chih-Sheng Lin
Journal:  Reprod Biol Endocrinol       Date:  2015-09-04       Impact factor: 5.211

5.  Developmental consequences of supplementing with matrix metallopeptidase-9 during in vitro maturation of heat-stressed bovine oocytes.

Authors:  Megan R Goodwin; Louisa A Rispoli; Rebecca R Payton; Arnold M Saxton; J Lannett Edwards
Journal:  J Reprod Dev       Date:  2016-07-21       Impact factor: 2.214

6.  Activity of Matrix Metalloproteinase 2 and 9 in Follicular Fluid and Seminal Plasma and Its Relation to Embryo Quality and Fertilization Rate.

Authors:  Mojgan Atabakhsh; Iraj Khodadadi; Iraj Amiri; Hossain Mahjub; Heidar Tavilani
Journal:  J Reprod Infertil       Date:  2018 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.